Key statistics
On Friday, Harvard Bioscience Inc (HBI:STU) closed at 2.38, 1.71% above its 52-week low of 2.34, set on Sep 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.40 |
---|---|
High | 2.40 |
Low | 2.34 |
Bid | 2.38 |
Offer | 2.54 |
Previous close | 2.42 |
Average volume | 0.00 |
---|---|
Shares outstanding | 43.61m |
Free float | 40.22m |
P/E (TTM) | -- |
Market cap | 119.93m USD |
EPS (TTM) | -0.2471 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Announcements
- Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
- Harvard Bioscience Announces Second Quarter 2024 Financial Results
- Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
- Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
- Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
- Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
- Harvard Bioscience Announces First Quarter 2024 Financial Results
- Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
- Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
More ▼